Recommendations include stronger CMS standards on SDoH data collection, greater transparency on supplemental benefit offerings within Medicare Plan Finder, and modifications to Star Ratings and risk adjustment to account for social risk factors
As Medicare Advantage continues to serve a proportionally higher-risk and more diverse enrollment population, a new report highlights innovative approaches to addressing social determinants of health (SDOH) for Medicare Advantage beneficiaries, while acknowledging barriers that remain.
Social determinants of health are non-medical factors that account for up to 55% of an individual’s health outcomes, according to the World Health Organization.
The report, conducted by NORC at the University of Chicago on behalf of Better Medicare Alliance’s Center for Innovation in Medicare Advantage, is informed by interviews with more than 20 experts from 14 organizations representing health plans, providers, health plan associations, not-for-profit social service organizations, and service and technology vendors.
NORC’S findings show a “dramatic increase in plan activity to address social needs” within Medicare Advantage – particularly in the areas of social isolation, transportation, housing, and food – buoyed by recent flexibilities allowing Medicare Advantage to offer expanded supplemental benefits for non-primarily health-related services and targeted to the chronically ill. Separate research cited in the report shows that 845 separate Medicare Advantage plans participated in Special Supplemental Benefits for the Chronically Ill (SSBCI) in 2021, compared to 245 the year prior.
NORC’s research also depicts how Medicare Advantage plans and partners collect data on beneficiaries’ social risk factors in the absence of consistent data collection guidelines and standards from the Centers for Medicare & Medicaid Services (CMS), including through investing in Artificial Intelligence and predictive analytics, and incorporating SDOH questions into Health Risk Assessments.
Still, barriers to further SDOH innovations remain. This includes technology limitations, misaligned incentives, and the disconnect between health care systems and social services. The report proposes potential solutions to spur greater investment in SDOH, including:
“As Medicare Advantage enrollment continues to soar – driven by diverse, medically complex, and at-risk beneficiaries – it is crucial that it be equipped with the tools to deliver whole-person care to this increasingly vulnerable population,” said Kenneth Thorpe, PhD, Chair of the Better Medicare Alliance Board of Directors and Chair of the Department of Health Policy and Management in the Rollins School of Public Health at Emory University. “This report paints an encouraging picture of the significant investments Medicare Advantage plans and partners are already making in this space, with the number of Medicare Advantage plans providing SSBCI increasing more than three-fold in a single year. Sensible policy changes can spur further innovation. From clear, consistent standards on SDOH data collection, to putting Value-Based Insurance Design to work for beneficiaries and modernizing risk adjustment and Star Ratings to reflect the reality of SDOH’s impact on health outcomes, this report offers a vision for a future where social needs are seen, met, and fully integrated into the health care experience.”
Caroline Pearson, senior vice president at NORC said the healthcare system recognizes the significant impact of unmet social needs on peoples’ health and wellbeing.
"However, we lack a systematic approach for identifying social needs, paying for interventions to address those needs, and evaluating the outcomes of these programs," Pearson said. "With policy support, Medicare Advantage plans can play a crucial role in addressing these social determinants of health."
35th World AIDS Day Marks 20 Years of PEPFAR: Challenges and Strategies to Combat HIV/AIDS
November 29th 2023PEPFAR, having invested $100 billion and saved 25 million lives in the global fight against HIV/AIDS, faces Congressional hurdles in its reauthorization due to abortion debates. Despite widespread support and no evidence of abortion-related activities, the legislative process is at a standstill. Members of PEPFAR and authors of a recent editorial stress the significance of PEPFAR and advocate for integrating behavioral and social science into healthcare programs to achieve UNAIDS targets and address barriers in HIV/AIDS testing and treatment.
Read More
Bridging the Diversity Gap in Rare Disease Clinical Trials with Harsha Rajasimha of IndoUSrare
November 8th 2023Briana Contreras, an editor with Managed Healthcare Executive, spoke with Harsha Rajasimha, MD, founder and executive chairman of IndoUSrare, in this month's episode of Tuning in to the C-Suite podcast. The conversation was about how the disparity in diversity and ethnicity in rare disease clinical trials in the U.S. has led to gaps in understanding diseases and conditions, jeopardizing universal health, and increasing the economic burden of healthcare.
Listen
Managing Editor of Managed Healthcare Executive, Peter Wehrwein, had a discussion with William Shrank, M.D., a venture partner with Andreessen Horowitz, a venture capital firm in Menlo Park, California, about how artificial intelligence's role is improving healthcare, where we are today with value-based care and the ongoing efforts of reducing waste in the healthcare space for this episode of the "What's on Your Mind" podcast series.
Listen
35th World AIDS Day Marks 20 Years of PEPFAR: Challenges and Strategies to Combat HIV/AIDS
November 29th 2023PEPFAR, having invested $100 billion and saved 25 million lives in the global fight against HIV/AIDS, faces Congressional hurdles in its reauthorization due to abortion debates. Despite widespread support and no evidence of abortion-related activities, the legislative process is at a standstill. Members of PEPFAR and authors of a recent editorial stress the significance of PEPFAR and advocate for integrating behavioral and social science into healthcare programs to achieve UNAIDS targets and address barriers in HIV/AIDS testing and treatment.
Read More
Bridging the Diversity Gap in Rare Disease Clinical Trials with Harsha Rajasimha of IndoUSrare
November 8th 2023Briana Contreras, an editor with Managed Healthcare Executive, spoke with Harsha Rajasimha, MD, founder and executive chairman of IndoUSrare, in this month's episode of Tuning in to the C-Suite podcast. The conversation was about how the disparity in diversity and ethnicity in rare disease clinical trials in the U.S. has led to gaps in understanding diseases and conditions, jeopardizing universal health, and increasing the economic burden of healthcare.
Listen
Managing Editor of Managed Healthcare Executive, Peter Wehrwein, had a discussion with William Shrank, M.D., a venture partner with Andreessen Horowitz, a venture capital firm in Menlo Park, California, about how artificial intelligence's role is improving healthcare, where we are today with value-based care and the ongoing efforts of reducing waste in the healthcare space for this episode of the "What's on Your Mind" podcast series.
Listen
2 Clarke Drive
Cranbury, NJ 08512